Related references
Note: Only part of the references are listed.A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers
Ashton C. Berger et al.
CANCER CELL (2018)
Molecular biomarkers for uterine leiomyosarcoma and endometrial stromal sarcoma
Hideaki Tsuyoshi et al.
CANCER SCIENCE (2018)
Novel lymphoid enhancer-binding factor 1-cytoglobin axis promotes extravasation of osteosarcoma cells into the lungs
Mongkol Pongsuchart et al.
CANCER SCIENCE (2018)
Exosomal zinc transporter ZIP4 promotes cancer growth and is a novel diagnostic biomarker for pancreatic cancer
Haoyi Jin et al.
CANCER SCIENCE (2018)
Expansion of the Gene Ontology knowledgebase and resources
S. Carbon et al.
NUCLEIC ACIDS RESEARCH (2017)
Bioinformatic analyses reveal a distinct Notch activation induced by STAT3 phosphorylation in the mesenchymal subtype of glioblastoma
Wen Cheng et al.
JOURNAL OF NEUROSURGERY (2017)
A p53 Super-tumor Suppressor Reveals a Tumor Suppressive p53-Ptpn14-Yap Axis in Pancreatic Cancer
Stephano S. Mello et al.
CANCER CELL (2017)
A combinatorial strategy using YAP and pan-RAF inhibitors for treating KRAS-mutant pancreatic cancer
Xiao Zhao et al.
CANCER LETTERS (2017)
The role of pancreatic cancer-derived exosomes in cancer progress and their potential application as biomarkers
H. Jin et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2017)
eIF5A-PEAK1 Signaling Regulates YAP1/TAZ Protein Expression and Pancreatic Cancer Cell Growth
Jan Strnadel et al.
CANCER RESEARCH (2017)
Association between small heat shock protein B11 and the prognostic value of MGMT promoter methylation in patients with high-grade glioma
Wen Cheng et al.
JOURNAL OF NEUROSURGERY (2016)
Bioinformatic profiling identifies an immune-related risk signature for glioblastoma
Wen Cheng et al.
NEUROLOGY (2016)
Quantitative secretomic analysis of pancreatic cancer cells in serum-containing conditioned medium
Peng Liu et al.
SCIENTIFIC REPORTS (2016)
Prediction of clinical outcome in glioblastoma using a biologically relevant nine-microRNA signature
Josie Hayes et al.
MOLECULAR ONCOLOGY (2015)
Randomized double-blinded, placebo-controlled phase II trial of simvastatin and gemcitabine in advanced pancreatic cancer patients
Jung Yong Hong et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)
Phase 2 Trial of Induction Gemcitabine, Oxaliplatin, and Cetuximab Followed by Selective Capecitabine-Based Chemoradiation in Patients With Borderline Resectable or Unresectable Locally Advanced Pancreatic Cancer
Nestor F. Esnaola et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
Emerging role of the KRAS-PDK1 axis in pancreatic cancer
Riccardo Ferro et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Multicenter phase II trial to investigate safety and efficacy of gemcitabine combined with cetuximab as adjuvant therapy in pancreatic cancer (ATIP)
H. Fensterer et al.
ANNALS OF ONCOLOGY (2013)
DAVID-WS: a stateful web service to facilitate gene/protein list analysis
Xiaoli Jiao et al.
BIOINFORMATICS (2012)
Integrative Survival-Based Molecular Profiling of Human Pancreatic Cancer
Timothy R. Donahue et al.
CLINICAL CANCER RESEARCH (2012)
Pancreatic Cancer
Manuel Hidalgo
NEW ENGLAND JOURNAL OF MEDICINE (2010)
FKBP51 Affects Cancer Cell Response to Chemotherapy by Negatively Regulating Akt
Huadong Pei et al.
CANCER CELL (2009)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Cytoscape: A software environment for integrated models of biomolecular interaction networks
P Shannon et al.
GENOME RESEARCH (2003)
Share Paper
